In the last years, the role of Cx46 in cancer has risen, mostly because results in animal models and human cell lines point out that this protein could be pro-tumorigenic and, moreover, it can be a key factor for the enhancement of EMT and CSC in cancer cells. This evidence concerns the gene GJA3 and cancer.